Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model

MLA

Jenna N. Regan, et al. “Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model.” Frontiers in Endocrinology, vol. 8, Dec. 2017. EBSCOhost, https://doi.org/10.3389/fendo.2017.00358.

APA

Jenna N. Regan, Carter Mikesell, Steven Reiken, Haifang Xu, Andrew R. Marks, Khalid S. Mohammad, Theresa A. Guise, & David L. Waning. (2017). Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model. Frontiers in Endocrinology, 8. https://doi.org/10.3389/fendo.2017.00358

Chicago

Jenna N. Regan, Carter Mikesell, Steven Reiken, Haifang Xu, Andrew R. Marks, Khalid S. Mohammad, Theresa A. Guise, and David L. Waning. 2017. “Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model.” Frontiers in Endocrinology 8 (December). doi:10.3389/fendo.2017.00358.